Jing Lin

1.9k total citations · 1 hit paper
73 papers, 1.3k citations indexed

About

Jing Lin is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jing Lin has authored 73 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 18 papers in Pulmonary and Respiratory Medicine and 17 papers in Oncology. Recurrent topics in Jing Lin's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Intracerebral and Subarachnoid Hemorrhage Research (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). Jing Lin is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Intracerebral and Subarachnoid Hemorrhage Research (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). Jing Lin collaborates with scholars based in China, United States and Austria. Jing Lin's co-authors include Ling Wang, Da‐Jin Li, Na Zhang, Lu Lu, Jinhong Chen, Weiqing Shao, Zhifei Lin, Hu‐Liang Jia, Jing Zhou and Jubo Zhang and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Jing Lin

67 papers receiving 1.2k citations

Hit Papers

Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Im... 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti–Programmed Cell Death‐1 in HCC
    2021 212 citations Chenhe Yi, Zhifei Lin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Lin China 18 313 219 205 198 167 73 1.3k
Maoyin Pang United States 18 634 2.0× 216 1.0× 202 1.0× 148 0.7× 217 1.3× 52 1.5k
Jinpeng Li China 20 678 2.2× 161 0.7× 232 1.1× 115 0.6× 212 1.3× 77 1.5k
Zhangzhe Peng China 22 487 1.6× 294 1.3× 129 0.6× 145 0.7× 152 0.9× 79 1.3k
Laura Necula Romania 18 563 1.8× 285 1.3× 293 1.4× 213 1.1× 226 1.4× 34 1.5k
Maria Majdan Poland 20 276 0.9× 145 0.7× 123 0.6× 242 1.2× 153 0.9× 169 1.4k
Tongyu Zhu China 20 426 1.4× 147 0.7× 100 0.5× 281 1.4× 251 1.5× 77 1.3k
Wenjie Wang China 20 467 1.5× 366 1.7× 185 0.9× 160 0.8× 246 1.5× 94 1.3k
Simona Granata Italy 23 634 2.0× 155 0.7× 99 0.5× 144 0.7× 266 1.6× 62 1.6k
Naoka Murakami United States 19 315 1.0× 148 0.7× 445 2.2× 263 1.3× 251 1.5× 68 1.3k

Countries citing papers authored by Jing Lin

Since Specialization
Citations

This map shows the geographic impact of Jing Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Lin more than expected).

Fields of papers citing papers by Jing Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Lin. The network helps show where Jing Lin may publish in the future.

Co-authorship network of co-authors of Jing Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Lin. A scholar is included among the top collaborators of Jing Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Lin. Jing Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yuan, Weiguang, Yajie Gong, Siwei Li, et al.. (2025). Engineered crRNA Drives RPA‐T7‐CRISPR/Cas14a Cascade for Ultrasensitive Detection of ctDNA PIK3CA H1047R. Advanced Science. 12(44). e07126–e07126. 2 indexed citations
3.
4.
Shao, Weiqing, Yitong Li, Xiaochen Ma, et al.. (2024). Inhibition of PCSK9 prevents and alleviates cholesterol gallstones through PPARα-mediated CYP7A1 activation. Metabolism. 152. 155774–155774. 17 indexed citations
5.
Wang, Xiangyu, Rui Zhang, Jiahao Han, et al.. (2023). Early Circulating Tumor DNA Dynamics Predict Neoadjuvant Therapy Response and Recurrence in Colorectal Liver Metastases: A Prospective Study. Annals of Surgical Oncology. 30(8). 5252–5263. 8 indexed citations
6.
Shao, Weiqing, Yiran Chen, Zhifei Lin, et al.. (2023). SREBP2 inhibitor betulin sensitizes hepatocellular carcinoma to lenvatinib by inhibiting the mTOR/IL-1β pathway. Acta Biochimica et Biophysica Sinica. 55(9). 1479–1486. 10 indexed citations
7.
Zhang, Bo, Baorui Tao, Chenhe Yi, et al.. (2022). Dual immune checkpoint inhibitors or combined with anti-VEGF agents in advanced, unresectable hepatocellular carcinoma. European Journal of Internal Medicine. 111. 37–46. 7 indexed citations
8.
9.
Xu, Jiarui, Xin Chen, Jing Lin, et al.. (2022). Improvement of cardiac function after coronary artery bypass grafting surgery reduces the risk of postoperative acute kidney injury. Clinical Cardiology. 45(2). 173–179. 3 indexed citations
10.
Lin, Jing, Zhen Qin, Xinhao Liu, et al.. (2021). Retrograde inferior vena caval perfusion for total aortic arch replacement surgery: a randomized pilot study. BMC Cardiovascular Disorders. 21(1). 193–193. 3 indexed citations
11.
Jiang, Nan, Dalian Qin, Jing Yang, et al.. (2021). Identification of Core Genes Related to Progression and Prognosis of Hepatocellular Carcinoma and Small-Molecule Drug Predication. Frontiers in Genetics. 12. 608017–608017. 5 indexed citations
12.
Shao, Weiqing, Wenwei Zhu, Jing Lin, et al.. (2019). Liver X Receptor Agonism Sensitizes a Subset of Hepatocellular Carcinoma to Sorafenib by Dual-Inhibiting MET and EGFR. Neoplasia. 22(1). 1–9. 22 indexed citations
13.
Du, Yan, Jing Lin, Ying Dong, et al.. (2018). Detection of chromosome abnormalities using current noninvasive prenatal testing: A multi-center comparative study. BioScience Trends. 12(3). 317–324. 6 indexed citations
14.
Yang, Ming, Xiaoyi Hu, Lingling Xie, et al.. (2018). Validation of the Chinese version of the Mini Sarcopenia Risk Assessment questionnaire in community-dwelling older adults. Medicine. 97(37). e12426–e12426. 19 indexed citations
15.
Lin, Jing, Zhen Qin, Hong Qian, et al.. (2018). A novel catheter with retractable stent that can prevent aortic insufficiency during left ventricular assist. PLoS ONE. 13(4). e0194658–e0194658.
16.
Zhang, Na, Yang Zhang, Jing Lin, et al.. (2017). Low-density lipoprotein receptor deficiency impaired mice osteoblastogenesis <i>in vitro </i>. BioScience Trends. 11(6). 658–666. 8 indexed citations
17.
Liu, Junfeng, Deren Wang, Jie Li, et al.. (2017). Cerebral Microbleeds Do Not Predict Hemorrhagic Transformation in Acute Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease. Current Neurovascular Research. 14(2). 104–109. 5 indexed citations
18.
Yin, Tao, Delu Yin, Kun Qin, et al.. (2016). Survey on the service contract signature of primary medical and health institutions in China. Zhonghua yiyuan guanli zazhi. 32(3). 213–216. 1 indexed citations
19.
Lin, Jing, Ming Lü, Weiqing Shao, et al.. (2016). Osteopontin Deficiency Alters Biliary Homeostasis and Protects against Gallstone Formation. Scientific Reports. 6(1). 30215–30215. 10 indexed citations
20.
Lin, Jing, et al.. (1999). [Gonadotropin releasing hormone agonists in the treatment of adenomyosis with infertility].. PubMed. 34(4). 214–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maoyin Pang Breakdown of academic impact, for papers by Jinpeng Li Breakdown of academic impact, for papers by Zhangzhe Peng Breakdown of academic impact, for papers by Laura Necula Breakdown of academic impact, for papers by Maria Majdan Breakdown of academic impact, for papers by Tongyu Zhu Breakdown of academic impact, for papers by Wenjie Wang Breakdown of academic impact, for papers by Simona Granata Breakdown of academic impact, for papers by Naoka Murakami
Rankless by CCL
2026